0HNC Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Biomarin Pharmaceutical Inc

Watchlist Manager

Watchlist

Price: 57.445 USD 1.8% Market Closed

Market Cap: $11B

	Biomarin Pharmaceutical Inc LSE:0HNC	US
	China Resources Beer Holdings Co Ltd HKEX:291	HK
W	Williams Companies Inc LSE:0LXB	US
	Seagate Technology Holdings PLC NASDAQ:STX	IE
	Teleflex Inc NYSE:TFX	US
	Huali Industrial Group Co Ltd SZSE:300979	CN
	Muenchener Rueckversicherungs Gesellschaft in Muenchen AG XETRA:MUV2	DE
	Coloplast A/S CSE:COLO B	DK
	Kinarus Therapeutics Holding AG SIX:KNRS	CH
P	PALTAC Corp TSE:8283	JP
	Japan Tobacco Inc OTC:JAPAF	JP
A	Atlantia SpA F:AU9	IT
	NGL Energy Partners LP NYSE:NGL	US
	Kirin Holdings Co Ltd OTC:KNBWY	JP
X	Xtb SA WSE:XTB	PL

Profitability Summary

Biomarin Pharmaceutical Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

80%

Strong 3Y Average Gross Margin

79%

Gross Margin is Increasing

77% > 80%

Low Operating Margin

10%

Sustainable 3Y Average Operating Margin

15%

Operating Margin is Increasing

3% > 10%

Low Net Margin

Sustainable 3Y Average Net Margin

11%

Net Margin is Increasing

3% > 8%

Exceptional Free Cash Flow Margin

23%

Strong 3Y Average Free Cash Flow Margin

14%

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.